We are live on ! Find out more
CBAY

Cymabay Therapeutics
CBAY

Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

1 hedge funds and large institutions have $21.1K invested in Cymabay Therapeutics in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 198 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 200 → 1 (-199)

100% less funds holding in top 10

Funds holding in top 10: 10 → 0 (-10)

100% less capital invested

Capital invested by funds: $2.73B → $21.1K (-$2.73B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 198

Holders
1
Holders Change
-199
Holders Change %
-99.5%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
198
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$262M
2
BlackRock
BlackRock
New York
-$227M
3
RCM
RA Capital Management
Massachusetts
-$164M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$149M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$144M
Name Holding Trade Value Shares
Change 		Change in
Stake
Nisa Investment Advisors
176
Nisa Investment Advisors
Missouri
– -$28.6K -1,211 Closed
HFM
177
Harvest Fund Management
China
– -$26K -1,076 Closed
EWA
178
EverSource Wealth Advisors
Alabama
– -$18.6K -786 Closed
PA
179
Parallel Advisors
California
– -$17.2K -730 Closed
Daiwa Securities Group
180
Daiwa Securities Group
Japan
– -$11K -464 Closed
QCG
181
Quadrant Capital Group
Ohio
– -$8.9K -377 Closed
S
182
SignatureFD
Georgia
– -$8.62K -365 Closed
PTC
183
Private Trust Company
Ohio
– -$8.03K -340 Closed
HIM
184
Hillsdale Investment Management
Ontario, Canada
– -$7.32K -310 Closed
Northwestern Mutual Wealth Management
185
Northwestern Mutual Wealth Management
Wisconsin
– -$5.91K -250 Closed
GI
186
GAMMA Investing
California
– -$5.17K -220 Closed
LC
187
Lindbrook Capital
California
– -$5.15K -218 Closed
WTA
188
Washington Trust Advisors
Massachusetts
– -$3.61K -153 Closed
FFA
189
Farther Finance Advisors
California
– -$3.19K -135 Closed
AF
190
Allworth Financial
California
– -$3.12K -132 Closed
AWM
191
Able Wealth Management
New Jersey
– -$1.96K -83 Closed
AWM
192
Activest Wealth Management
Florida
– -$1.94K -69 Closed
FFO
193
Fortitude Family Office
Arizona
– -$1.13K -48 Closed
ASN
194
Advisory Services Network
Georgia
– -$968 -41 Closed
EWP
195
Elevation Wealth Partners
California
– -$448 -30 Closed
PS
196
Principal Securities
Iowa
– -$283 -12 Closed
Federated Hermes
197
Federated Hermes
Pennsylvania
– -$71 -3 Closed
MIM
198
Macroview Investment Management
Maryland
– -$24 -1 Closed
4 5 6 7
8

CBAY Hedge Fund Activity: Q1 2024 in Review

1 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Cymabay Therapeutics (CBAY) for Q1 2024, worth a combined $21.1K — down 100% from $2.73B a quarter earlier.

Sellers outnumbered buyers: 198 funds closed out of CBAY and 0 opened new positions — a net loss of 198 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $262M sold.

  • 1 institutional investor held Cymabay Therapeutics (CBAY) as of Q1 2024, down from 200 in Q4 2023.
  • Funds reported $21.1K of Cymabay Therapeutics stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Cymabay Therapeutics positions in Q1 2024 and 198 closed out, a net change of -198 holders.
  • The largest Cymabay Therapeutics seller in Q1 2024 was Avoro Capital Advisors, an estimated $262M sold.

Based on aggregated 13F filings for Q1 2024.